April 6-9, 2017

Hilton Orlando Bonnet creek

The 23rd Annual Interventional Cardiology Fellows Course is sponsored by the Cardiovascular Research Foundation and partially funded through educational grants from commercial supporters.

The educational grant support of our industry colleagues, who, like the Cardiovascular Research Foundation, are dedicated to educating medical professionals and the public to enhance patient outcomes, helps to make this program possible.

The Cardiovascular Research Foundation gratefully acknowledges the Fellows Course

MAJOR BENEFACTORS:

  • Abbott
  • Boston Scientific Corporation
  • Medtronic

BENEFACTORS:

  • ABIOMED, Inc.
  • AstraZeneca
  • Cardiovascular Systems, Inc.
  • Chiesi USA, Inc.
  • Cordis, A Cardinal Health Company
  • Edwards Lifesciences
  • Spectranetics Corporation
  • St. Jude Medical, Inc.

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational programs. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.